Capecitabine vs 5‐FU‐containing regimens
Tumour response · people with advanced gastric cancer
It is very uncertain whether capecitabine changes tumour response compared with 5‐FU‐containing regimens (very low certainty).
1 finding from 1 review
- OR 0.85 [0.4, 1.79]4 studies · 636 participantsVery low